India is launching cheap weight-loss drugs — but Novo Nordisk is betting its brands will stay on top

Written on 03/24/2026

Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
Read full article